Physician profile
Eric Hermansen
NPI 1154412450
$211.43
in general payments reported to CMS, 2019-2025
10 companies · $55.67 in 2025
The $55.67 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.19 · 2020: $11.49 · 2021: $12.33 · 2022: $18.79 · 2023: $41.78 · 2024: $57.18 · 2025: $55.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $38.25 | 2024 | |
| Glaxosmithkline, LLC. | $30.28 | 2020-2022 | |
| Lilly USA, LLC | $27.30 | 2025 | Mounjaro |
| Abbott Laboratories | $22.03 | 2023 | Freestyle Libre 3 |
| Pfizer INC. | $19.75 | 2023 | |
| Dexcom, INC. | $18.93 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $14.79 | 2025 | Farxiga |
| Medtronic Vascular, INC. | $14.19 | 2019 | |
| Exact Sciences Corporation | $13.58 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hermansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.